BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15997717)

  • 1. [Autoimmune polyendocrine syndrome (APS). Chief symptoms depend on involved organs].
    Kolyvanos Naumann U; Furrer J; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Jun; 94(24-25):1007-12; quiz 1013. PubMed ID: 15997717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Seric 21-hydroxilase antibodies in patients with anti-microsomal fraction antibodies. Autoimmune polyendocrine syndrome].
    Botta S; Roveto S; Rimoldi D
    Medicina (B Aires); 2007; 67(2):143-6. PubMed ID: 17593598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tiredness, hyperpigmentation, weight loss, nausea and vomiting. Polyglandular autoimmune syndrome (PAS) type 2].
    Locher R; Kohler S; Schwanda S; Schmid C
    Praxis (Bern 1994); 2010 Oct; 99(20):1223-8. PubMed ID: 20931500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune polyendocrine syndrome type 1 (APS-1) as a model for understanding autoimmune polyendocrine syndrome type 2 (APS-2).
    Michels AW; Eisenbarth GS
    J Intern Med; 2009 May; 265(5):530-40. PubMed ID: 19382992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [19-year-old patient with adrenal cortex insufficiency--only the tip of the iceberg. Polyendocrine autoimmune syndrome type II (Schmidt syndrome)].
    Lipowsky C; Schorl-Schweikardt BA; Kehl O; Brändle M
    Praxis (Bern 1994); 2008 Jan; 97(2):77-81. PubMed ID: 18303665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction.
    Betterle C; Dal Pra C; Mantero F; Zanchetta R
    Endocr Rev; 2002 Jun; 23(3):327-64. PubMed ID: 12050123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Schmidt syndrome--a case report].
    Stradner F; Binter G; Langsteger W; Eber O
    Acta Med Austriaca; 1992; 19(5):144-8. PubMed ID: 1298144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune polyglandular syndrome, type II.
    Majeroni BA; Patel P
    Am Fam Physician; 2007 Mar; 75(5):667-70. PubMed ID: 17375512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addisonian crisis precipitated by thyroxine therapy: a complication of type 2 autoimmune polyglandular syndrome.
    Graves L; Klein RM; Walling AD
    South Med J; 2003 Aug; 96(8):824-7. PubMed ID: 14515930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune polyendocrine syndromes.
    Cutolo M
    Autoimmun Rev; 2014 Feb; 13(2):85-9. PubMed ID: 24055063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [APS I--a severe autoimmune disease with endocrine and non-endocrine symptoms].
    Gustafsson J; Alimohammadi M; Ekwall O; Gebre-Medhin G; Halldin-Stenlid M; Hedstrand H; Landgren E; Nilsson T; Rorsman F; Sköldberg F; Winqvist O; Kämpe O
    Lakartidningen; 2004 Jun; 101(24):2096-8, 2101-3. PubMed ID: 15282984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune polyglandular syndrome type-1.
    Patel ML; Sachan R; Patil MR; Mishra A
    J Assoc Physicians India; 2012 Aug; 60():61. PubMed ID: 23405531
    [No Abstract]   [Full Text] [Related]  

  • 13. The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1.
    Lankisch TO; Jaeckel E; Strassburg CP
    Semin Liver Dis; 2009 Aug; 29(3):307-14. PubMed ID: 19676003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Manifestation of adrenal insufficiency after administration of levothyroxine in a patient with polyglangular autoimmune syndrome type II (Schmidt-syndrome)].
    Canbay A; Gieseler R; Ella R; Fink H; Saller B; Mann K
    Internist (Berl); 2000 Jun; 41(6):588-91. PubMed ID: 10907192
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autoimmune polyglandular syndromes].
    Hansen MP; Kahaly GJ
    Dtsch Med Wochenschr; 2013 Feb; 138(7):319-26; quiz 327-8. PubMed ID: 23393002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic dissection of autoimmune polyendocrine syndrome type 2: common origin of a spectrum of phenotypes.
    Ballarini A; Lee-Kirsch MA
    Ann N Y Acad Sci; 2007 Sep; 1110():159-65. PubMed ID: 17911431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Schmidt Syndrome.
    Siniscalchi C; Moretti V; Cataldo S; Rocci A; Basaglia M; Tassoni MI; Quintavalla R
    Acta Biomed; 2018 Jan; 88(4):499-501. PubMed ID: 29350667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoimmune polyendocrine syndrome type 1].
    Proust-Lemoine E; Saugier-Veber P; Lefebvre H; Lefranc D; Prin L; Weill J; Carel JC; Wemeau JL
    Arch Pediatr; 2010 Jun; 17(6):597-8. PubMed ID: 20654797
    [No Abstract]   [Full Text] [Related]  

  • 19. Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I.
    Oftedal BE; Marthinussen MC; Erichsen MM; Tveitarås MK; Kjellesvik-Kristiansen A; Hammenfors D; Jonsson MV; Kisand K; Jonsson R; Wolff ASB
    Autoimmunity; 2017 Jun; 50(4):211-222. PubMed ID: 28686485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmune polyglandular syndrome in a 13-year old girl].
    Borgwardt L; Pedersen P; Peitersen B
    Ugeskr Laeger; 2008 Sep; 170(40):3145-7. PubMed ID: 18823610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.